Document Detail

Post-prandial intragastric and duodenal acidity are increased in patients with chronic pancreatitis.
MedLine Citation:
PMID:  10383529     Owner:  NLM     Status:  MEDLINE    
OBJECTIVES: Patients with chronic pancreatitis and exocrine insufficiency have lower intraduodenal pH compared to controls. It has been assumed that abnormal low intraduodenal pH in these patients not only results from impaired pancreatic bicarbonate secretion but also from an increased gastric acid load to the duodenum. METHODS: We have tested this hypothesis by combined intragastric and intraduodenal 24 h pH monitoring in nine chronic pancreatitis patients with exocrine pancreatic insufficiency and nine healthy control subjects during standardized test conditions. Postprandial gastrin and cholecystokinin release were also determined. RESULTS: Median 24-h intraduodenal pH (5.90 vs. 6.00) and intragastric pH (1.60 vs. 1.70) were not significantly different between patients and controls. However, in the 2-h postprandial periods intraduodenal pH was below five for a significantly higher percentage of time in chronic pancreatitis patients compared to controls (lunch: 14.5% vs. 0.17%, P=0.011; dinner: 24.1% vs. 5.75%, P=0.05). The post-dinner intragastric pH was below three for a significantly higher percentage of time in chronic pancreatitis patients vs. controls (72.2 vs. 48.9%, P=0.04). Postprandial gastrin release was not significantly different between the two groups. Postprandial secretion of cholecystokinin (CCK), as enterogastrone, was significantly (P < 0.01) reduced in chronic pancreatitis patients (78 +/- 13 pmol/L, 120 min) compared to controls (155 +/- 14 pmol/L, 120 min). CONCLUSIONS: Median intraduodenal and intragastric pH are not significantly decreased in patients with chronic pancreatitis and exocrine insufficiency but the postprandial time with an acidic pH in the duodenum (pH < 5) and in the stomach (pH < 3) is significantly (P </= 0.05) increased.
W P Geus; E H Eddes; H A Gielkens; K H Gan; C B Lamers; A A Masclee
Related Documents :
10383529 - Post-prandial intragastric and duodenal acidity are increased in patients with chronic ...
21084049 - Exocrine pancreatic function in patients with end-stage renal disease.
8272219 - Acute renal failure in patients with acute pancreatitis: prevalence, risk factors, and ...
16217179 - Update on the evaluation of pancreatic exocrine status in cystic fibrosis.
9088119 - The natural course of acute gallstone pancreatitis.
835559 - The usefulness of stool screening for diagnosing cholelithiasis in acute pancreatitis. ...
7172509 - Cellular immunity during follow-up of patients with sarcoidosis of varying duration.
11917259 - Hypercapnia in overlap syndrome: possible determinant factors.
21826679 - Regional body composition and functional impairment in patients with myotonic dystrophy.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Alimentary pharmacology & therapeutics     Volume:  13     ISSN:  0269-2813     ISO Abbreviation:  Aliment. Pharmacol. Ther.     Publication Date:  1999 Jul 
Date Detail:
Created Date:  1999-08-19     Completed Date:  1999-08-19     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  8707234     Medline TA:  Aliment Pharmacol Ther     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  937-43     Citation Subset:  IM    
Department of Intensive Care, Leyenburg Hospital, The Hague, The Netherlands; Department of Gastroenterology-Hepatology, Leiden University Medical Center, The Netherlands.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Case-Control Studies
Cholecystokinin / blood
Chronic Disease
Duodenum / metabolism*,  secretion
Exocrine Pancreatic Insufficiency / blood,  metabolism*
Gastric Mucosa / metabolism*
Gastrins / blood
Hydrogen-Ion Concentration
Middle Aged
Pancreatitis / blood,  metabolism*
Postprandial Period*
Time Factors
Reg. No./Substance:
0/Gastrins; 9011-97-6/Cholecystokinin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Altered oesophageal motility following the administration of the 5-HT1 agonist, sumatriptan.
Next Document:  A non-toxic analogue of a coeliac-activating gliadin peptide: a basis for immunomodulation?